Recombinant Interleukin-2 (rIL-2), aldesleukin.
Baigent
Greg
G
Chiron Corporation, Emeryville, CA 94608-4255, USA. Greg_Baigent@chiron.com
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007376:Interleukin-2 / Q000031:analogs & derivatives / Q000235:genetics / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000235:genetics / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; C082598:aldesleukin